Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $233.45
- Average 1Y price target
- $352.17+50.85%
- Agreement
- Low
Analysts agreement range is spread more than 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall3
- DCF3
- Return on equity4
- Return on assets4
- Debt / equity3
- P/E3
- P/B2
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 4 | $391.50 |
| Last quarter | 6 | $348.50 |
| Last year | 16 | $311.81 |
| All time | 34 | $244.53 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 23, 2026 | Barclays | maintain | Overweight | Overweight |
| Oct 22, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Oct 13, 2026 | Barclays | maintain | Overweight | Overweight |
| Oct 8, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Aug 26, 2026 | UBS | downgrade | Buy | Neutral |
| Jul 27, 2026 | Barclays | maintain | Overweight | Overweight |
| Jul 24, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Jul 21, 2026 | Barclays | maintain | Overweight | Overweight |
| Jul 17, 2026 | TD Cowen | maintain | Buy | Buy |
| Apr 27, 2026 | Barclays | maintain | Overweight | Overweight |
| Apr 24, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Apr 21, 2026 | Barclays | maintain | Overweight | Overweight |
| Apr 13, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Mar 24, 2026 | JP Morgan | downgrade | Overweight | Neutral |
| Oct 24, 2025 | Barclays | maintain | Overweight | Overweight |
| Oct 24, 2025 | Argus Research | maintain | Buy | Buy |
| Oct 23, 2025 | JMP Securities | maintain | Market Outperform | Market Outperform |
| Oct 23, 2025 | BMO Capital | maintain | Outperform | Outperform |
| Jul 25, 2025 | Barclays | maintain | Overweight | Overweight |
| Jul 23, 2025 | JMP Securities | maintain | Market Outperform | Market Outperform |
| May 23, 2025 | JMP Securities | maintain | Market Outperform | Market Outperform |
| May 23, 2025 | BMO Capital | maintain | Outperform | Outperform |
| Apr 29, 2025 | Argus Research | maintain | Buy | Buy |
| Apr 24, 2025 | Barclays | maintain | Overweight | Overweight |
| Apr 16, 2025 | BMO Capital | maintain | Outperform | Outperform |
| Jan 30, 2025 | RBC Capital | maintain | Outperform | Outperform |
| Jan 30, 2025 | Barclays | maintain | Overweight | Overweight |
| Jan 29, 2025 | JMP Securities | maintain | Market Outperform | Market Outperform |
| Jan 29, 2025 | BMO Capital | maintain | Outperform | Outperform |
| Jan 23, 2025 | Barclays | maintain | Overweight | Overweight |
| Oct 23, 2024 | Barclays | maintain | Overweight | Overweight |
| Oct 22, 2024 | TD Cowen | maintain | Hold | Hold |
| Oct 22, 2024 | JMP Securities | maintain | Market Outperform | Market Outperform |
| Oct 22, 2024 | BMO Capital | maintain | Outperform | Outperform |
| Oct 16, 2024 | Cleveland Research | upgrade | Neutral | Buy |
| Sep 30, 2024 | Barclays | maintain | Overweight | Overweight |
| Aug 13, 2024 | Barclays | maintain | Overweight | Overweight |
| Jul 31, 2024 | Argus Research | upgrade | Hold | Buy |
| Jul 23, 2024 | TD Cowen | maintain | Hold | Hold |
| Jul 23, 2024 | JMP Securities | maintain | Market Outperform | Market Outperform |